SCHEMBL8785000

SCHEMBL8785000

CCC(C)OC(=O)CN

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15593349 1.00
Sulfuric Acid SCHEMBL28444020 0.92 CA12 (0.40)
SCHEMBL18274711 0.83
SCHEMBL3486034 0.82 FAAH (0.42)
SCHEMBL21023233 0.82 FAAH (0.42)
SCHEMBL19443244 0.82 FAAH (0.42)
SCHEMBL19822064 0.82 CA12 (0.41)
SCHEMBL18636465 0.81 CYP19A1 (0.46)
Ethylamine SCHEMBL28151848 0.80 TSHR (0.39)
SCHEMBL1585397 0.80

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12497491-B2 Aqueous dispersions of amino-functionalized organopolysiloxanes pre-crosslinked with oxalatopolyethers WACKER CHEMIE AG (DE) 2025-12-16 US disclosed
US-20230374224-A1 AQUEOUS DISPERSIONS OF AMINO-FUNCTIONALIZED ORGANOPOLYSILOXANES PRE-CROSSLINKED WITH OXALATOPOLYETHERS WACKER CHEMIE AG (DE) 2023-11-23 US disclosed
CN-116390990-A Aqueous dispersions of amino-functional organopolysiloxanes pre-crosslinked with oxalic acid polyethers 瓦克化学股份公司 2023-07-04 CN disclosed
EP-3789411-A2 POLYMER RESIN Sumitomo Chemical Company, Limited (JP) 2021-03-10 EP disclosed
CN-108794520-B Synthesis method of boric acid citrate compounds including Eszolomide 北京大学 2020-07-24 CN disclosed
US-9849191-B2 Protein-polymer-drug conjugates MERSANA THERAPEUTICS, INC. (US) 2017-12-26 US disclosed
US-20170348424-A1 PROTEIN-POLYMER-DRUG CONJUGATES MERSANA THERAPEUTICS, INC. 2017-12-07 US disclosed
US-9808528-B2 Protein-polymer-drug conjugates and methods of using same MERSANA THERAPEUTICS, INC. (US) 2017-11-07 US disclosed
EP-3228325-A1 PROTEIN-POLYMER-DRUG CONJUGATES Mersana Therapeutics, Inc. (US) 2017-10-11 EP disclosed
US-9770519-B2 Protein-polymer-drug conjugates MERSANA THERAPEUTICS, INC. (US) 2017-09-26 US disclosed
WO-2014093640-A1 HYDROXY-POLMER-DRUG-PROTEIN CONJUGATES MERSANA THERAPEUTICS,INC. (US) 2014-06-19 WO disclosed
US-20140134127-A1 Protein-Polymer-Drug Conjugates MERSANA THERAPEUTICS, INC. (US) 2014-05-15 US disclosed
US-20140017265-A1 Terminally Modified Polymers and Conjugates Thereof MERSANA THERAPEUTICS, INC. 2014-01-16 US disclosed
WO-2014008375-A1 TERMINALLY MODIFIED POLYMERS AND CONJUGATES THEREOF MERSANA THERAPEUTICS, INC. (US) 2014-01-09 WO disclosed
CN-103228775-A Substrate cleaner for copper wiring, and method for cleaning copper wiring semiconductor substrate WAKO PURE CHEMICAL INDUSTRY CO LTD 2013-07-31 CN disclosed
US-20130101546-A1 Protein-Polymer-Drug Conjugates MERSANA THERAPEUTICS, INC. (US) 2013-04-25 US disclosed
EP-0506478-B1 Piperidine derivatives LILLY CO ELI (US) 1997-09-03 EP disclosed
US-5250542-A Prevention of side effects induced by narcotics used as analgesics such as constipation, nausea and vomiting; 1-carboxyalkyl-4-methyl-4-(3-oxyphenyl)piperidines such as alvimopan ELI LILLY AND COMPANY (US) 1993-10-05 US disclosed
EP-0506478-A1 Piperidine derivatives ELI LILLY AND COMPANY (US) 1992-09-30 EP disclosed
EP-0384314-A2 Diaminothiophenes BASF Aktiengesellschaft (DE) 1990-08-29 EP disclosed